We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00184223
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : June 6, 2016
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose for this study is to determine whether 2x45 minutes Motivational Interviewing given during hospital stay to acutely admitted psychiatric patients with substance use problems, can reduce substance use after discharge.

Condition or disease Intervention/treatment
Substance-Related Disorders Behavioral: Motivational Interviewing Other: Treatment as usual

Detailed Description:

The aims of the study are in a randomized controlled trial to compare the effects of 2 x 45 minutes Motivational Interviewing and standard treatment with standard treatment alone.All patients acutely admitted to Østmarka Psychiatric Hospital are evaluated for substance use, and all patients with substance use that give their consent to participate are randomized to Motivational Interviewing and standard treatment or standard treatment alone.

Substance use and function will be followed for two years.Admittances to hospital and contacts with primary health care for five years.


Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 135 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Care Provider)
Primary Purpose: Treatment
Official Title: Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use
Study Start Date : October 2004
Primary Completion Date : June 2005
Study Completion Date : June 2005

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: motivational interviewing
Manual guided motivational interviewing in addition to treatment as usual
Behavioral: Motivational Interviewing
2 sessions of 45 minutes each with manual guided motivational interviewing delivered individually by a trained therapist.
Other: Treatment as usual
Treatment as usual is individualized according to the clinical condition of the patients during the stay and in accordance with general national and international medical standards. It includes detoxification, pharmacotherapy, and general psychotherapy. Also, treatment is given for any coexisting non-substance-related disorder, including psychiatric disorders.
control group
treatment as usual
Other: Treatment as usual
Treatment as usual is individualized according to the clinical condition of the patients during the stay and in accordance with general national and international medical standards. It includes detoxification, pharmacotherapy, and general psychotherapy. Also, treatment is given for any coexisting non-substance-related disorder, including psychiatric disorders.


Outcome Measures

Primary Outcome Measures :
  1. Substance use and function questionnaire [ Time Frame: 2 years ]

Secondary Outcome Measures :
  1. Admissions to hospital [ Time Frame: 2 years ]
  2. Number of contacts with primary ealth care [ Time Frame: 2 years ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • substance use
  • acutely admitted to psychiatric hospital

Exclusion Criteria:

  • dementia
  • serious brain damage
  • not speaking Norwegian or English
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00184223


Locations
Norway
Østmarka Psychiatric Department, St. Olavs Hospital, University Hospital of Trondheim
Trondheim, Norway
Sponsors and Collaborators
Norwegian University of Science and Technology
St. Olavs Hospital
Investigators
Principal Investigator: Gunnar Morken, MD PhD Norwegian University of Science and Technology
More Information

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00184223     History of Changes
Other Study ID Numbers: GB-MI-2004
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: June 6, 2016
Last Verified: May 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Norwegian University of Science and Technology:
Motivational Interviewing
Substance abuse
Acuteley admitted psychiatric patients
Emergency Services, Psychiatric

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders